ARCHIVES

Abstracts Of Papers Presented By Breast Cancer Task Force

This article is from The Cancer Letter archive.

Vol. 02 No. 38 | September 17, 1976

Download PDF Visit The Full Archive

Related Articles

Single-Agent Phase III Trial Comparing Vectibix to Erbitux Meets Primary Endpoint

May 31, 2013

Cancer Letter Editor Wine Reporting Awards

June 11, 1999

Half-Percent NIH, NCI Budget Raise Is Not Enough, Advocates Say

December 19, 2014

FDA Approves Aranesp For Chemo-Induced Anemia

August 30, 2002

LAK/IL-2 Extramural Trials Expanded to 20 More cancers

January 8, 1988

In Brief: Fox Chase Joins Temple Health System, Expands Outpatient and Surgical Services

July 6, 2012